Skip to Main Content

Author Details

Ann-Marie Patch
QIMR Berghofer Medical Research Institute
2005
82
39
PMIDPaper TitleJournal TitlePublished Year
36938641Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.Cancer Cytopathol2023
37927461Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report.Front Oncol2023
36938641Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.Cancer Cytopathol2023
36739348Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.Leukemia2023
37927461Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report.Front Oncol2023
36739348Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.Leukemia2023
35012638Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.Genome Med2022
35637530Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.Genome Med2022
35570070Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.Blood Rev2022
35849877Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.ESMO Open2022
36699384qmotif: determination of telomere content from whole-genome sequence data.Bioinform Adv2022
36452869Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis.Cell Rep Methods2022
35012638Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.Genome Med2022
35637530Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.Genome Med2022
35570070Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.Blood Rev2022
35849877Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.ESMO Open2022
36452869Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis.Cell Rep Methods2022
36699384qmotif: determination of telomere content from whole-genome sequence data.Bioinform Adv2022
33439897Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.PLoS Pathog2021
34076666Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.JAMA Dermatol2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33439897Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.PLoS Pathog2021
34076666Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.JAMA Dermatol2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
32384699<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.Cancers (Basel)2020
32414751FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.Clin Cancer Res2020
31935636Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.Neoplasia2020
32384699<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.Cancers (Basel)2020
33067454Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.Nat Commun2020
33053644The Impact of Next Generation Sequencing in Cancer Research.Cancers (Basel)2020
31935636Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.Neoplasia2020
33053644The Impact of Next Generation Sequencing in Cancer Research.Cancers (Basel)2020
33067454Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.Nat Commun2020
32414751FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.Clin Cancer Res2020
30279471Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease.Genet Med2019
30446706Correction: Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease.Genet Med2019
30279471Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease.Genet Med2019
30178487Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.Int J Cancer2019
31090900Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.Ann Oncol2019
31464824Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.Melanoma Res2019
30736342Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.Cancers (Basel)2019
30954552Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.Cell Mol Gastroenterol Hepatol2019
30717762Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.BMC Med Genomics2019
31320640Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.Nat Commun2019
30178487Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.Int J Cancer2019
31464824Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.Melanoma Res2019
31320640Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.Nat Commun2019
30954552Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.Cell Mol Gastroenterol Hepatol2019
30736342Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.Cancers (Basel)2019
31090900Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.Ann Oncol2019
  • 1 - 50 of 164

Recommended Authors

Samsung Genome Institute, Samsung Medical Center
Career Start Year 2013
Number of shared co-authors 2
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2011
Number of shared co-authors 32
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 17
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 1
College of Life Sciences, University of Chinese Academy of Sciences
Career Start Year 2007
Number of shared co-authors 17
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 14
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 30
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 20
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 25
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 19
University of California
Career Start Year 2003
Number of shared co-authors 6
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 33
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 13
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 36
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 8
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 39
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 8
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 7
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 9
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 23
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 9
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 21
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 4
University of Washington
Career Start Year 1996
Number of shared co-authors 21
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 9
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 20
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 42
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 48
The Ohio State University
Career Start Year 1988
Number of shared co-authors 32
Broad Institute
Career Start Year 1983
Number of shared co-authors 40

Collaborators

QIMR Berghofer Medical Research Institute
Co-authored papers 47
QIMR Berghofer Medical Research Institute
Co-authored papers 41
QIMR Berghofer Medical Research Institute
Co-authored papers 36
The University of Melbourne
Co-authored papers 23
Royal Devon University Healthcare NHS Foundation Trust
Co-authored papers 21
Co-authored papers 19
The University of Queensland Diamantina Institute, The University of Queensland
Co-authored papers 13
Adelaide Medical School, The University of Adelaide
Co-authored papers 12
QIMR Berghofer Medical Research Institute
Co-authored papers 11
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Co-authored papers 10
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 9
Co-authored papers 8
Queensland University of Technology
Co-authored papers 7
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers 7
University of Queensland
Co-authored papers 6
Westmead Hospital
Co-authored papers 6
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 6
Peter MacCallum Cancer Centre
Co-authored papers 6
Westmead Hospital
Co-authored papers 5
Baylor College of Medicine
Co-authored papers 5
Westmead Clinical School, University of Sydney
Co-authored papers 5
QIMR Berghofer Medical Research Institute
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 5
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 5
Peter MacCallum Cancer Centre
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
QIMR Berghofer Medical Research Institute
Co-authored papers 4